Lack of α2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice

Blood

Volumn 102, Issue 10, 2003, Pages 3621-3628

  Matsuno, Hiroyuki ^a   Ishisaki, Akira ^b   Nakajima, Keiichi ^b   Okada, Kiyotaka ^b   Ueshima, Shigeru ^b   Matsuo, Osamu ^b   Kozawa, Osamu ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIBODY; PLASMINOGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1 ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; BLOOD VESSEL INJURY; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEALING; HISTOPATHOLOGY; INJECTION; INTIMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0242494904     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0700     Document Type: Article

References (34)

1. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 1989;8:3801-3806.
2. Karkkainen MJ, Makinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol. 2002;4: E2-5.
3. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
4. Taghavi S, Abraham D, Riml P, et al. Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant. 2002;21:600-603.
5. Matsuno H, Kozawa O, Yoshimi N, et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood. 2002;100:2487-2493.
6. Forstreuter F, Lucius R, Mentlein R. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol. 2002;132:93-98.
7. Spyridopoulos I, Luedemann C, Chen D, et al. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol. 2002;22:901-906.
8. Carmeliet P, Moons L, Dewerchin M, et al. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci. 1997;811:191-206.
9. Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
10. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
11. Montes R, Paramo JA, Angles-Cano E, et al. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-anti-plasmin complexes in plasma. Br J Haematol. 1996;92:979-985.
12. Wiman B, Collen D. Molecular mechanism of physiological fibrinolysis. Nature. 1987;272:549-550.
13. Lijnen HR, De Cock F, Van Hoef B, et al. Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem. 1994;224:143-149.
14. Carmeliet P, Collen D. Gene manipulation and transfer of the plasminogen and coagulation system in mice. Semin Thromb Hemost. 1996;22:525-542.
15. Montes R, Paramo JA, Angles-Cano E, et al. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-anti-plasmin complexes in plasma. Br J Haematol. 1996;92:979-985.
16. Bayes-Genis A, Guindo J, Oliver A, et al. Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina. Thromb Haemost. 1999;81:865-868.
17. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
18. Westerband A, Crouse D, Richter LC, et al. Vein adaptation to arterialization in an experimental model. J Vasc Surg. 2001;33:561-569.
19. Carmeliet P, Schoonjans L, Kieckens L, et al. Physiological consequence of loss of plasminogen activator gene function in mice. Nature. 1994;368:419-424.
20. Okada K, Lijnen HR, Dewerchin M, et al. Characterization and targeting of the murine alpha2-antiplasmin gene. Thromb Haemost. 1997;78:1104-1110.
21. Matsuno H, Kozawa O, Okada K, et al. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice. Thromb Haemost. 2002;87:98-104.
22. Matsuno H, Kozawa O, Niwa M, et al. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury. Thromb Haemost. 1999;81:601-604.
23. Matsuno H, Stassen JM, Vermylen J, et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
24. Matsuno H, Kozawa O, Niwa M, et al. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated audntricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery. Circulation. 1997;96:1299-1304.
25. Okada K, Ueshima S, Fukao H, et al. Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase. Arch Biochem Biophys. 2001;393:339-341.
26. Ross R, Glomset J, Kariya B, et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974;71:1207-1210.
27. Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res. 1999;253:117-130.
28. Lijnen HR, Okada K, Matsuo O, et al. Alpha2-anti-plasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood. 1999;93:2274-2281.
29. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998;95:15809-15814.
30. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
31. Chen D, Asahara T, Krasinski K, et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation. 1999;100:849-854.
32. Hiltunen MO, Laitinen M, Turunen MP, et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation. 2000;102:2262-2268.
33. Celletti FL, Waugh JM, Amabile PG, et al. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel. J Vasc Interv Radiol. 2002;13:703-707.
34. Brower V. Genetech enlightens other angiogenesis programs. Nat Biotechnol. 1999;17:326-327.